The Brazilian Patent and Trademark Office (BPTO) has just published a notification informing that the limit of 800 Patent Prosecution Highway (PPH) requests … Brazilian Patent Office (BPO) announces that the limit of PPH requests for 2023 has been reached
The Provisional Measure 1.152/2022 (“MP 1152”) that amended the Transfer Price (PT) rules had its final text approved by the National Congress … The adoption of Transfer Prices (PT) by Law 14.596/2023 and the new BPTO process guidelines
Brazilian Data Protection Authority (ANPD) applied, on July 6th, the first sanction for non-compliance with the Brazilian General Data Protection Law (LGPD). … Brazilian Data Protection Authority issues its first official fine after almost three years in force
The Brazilian Patent Office (BPO) has instituted, by Ordinance No. 025, dated July 3rd, 2023, which will be in force on August … Brazil becomes a Contracting Party of the Hague Agreement for Registration of Industrial Designs
The Brazilian Superior Court (“STJ”) has recently ruled on puffery in advertising in a case between Unilever (owner of the Hellmann’s brand) … Brazilian Superior Court recognizes the legitimacy of Heinz’s use of exaggerated advertising
Jokes aside in the title, despite having discussed for years the possibility of registering or not the famous red sole of Louboutin … They aimed at the Louboutin sole, but hit the Osklen sneaker!
In an online meeting convened by the INPI on May 25, 2023, representatives of the main national associations for studies and intellectual … Brazilian Patent Office (INPI) announces plan to grant patents in just 2 years
On May 9, 2023, the BPTO released the INPI/CPAPD technical opinion No. 01/2023, which provides guidance on the patentability of inventions related … The Brazilian PTO published a new technical opinion regarding the patentability of inventions related to transgenic plants
The BPTO published, on April 11, 2023, the Management Report for fiscal year 2022, which highlights the results achieved in view of … BPTO Management Report 2022: Patent overview
Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common … “Brazil: The patent combination conundrum” for LSIPR Magazine
